EBS - Emergent BioSolutions Inc. (EBS) Q4 2023 Earnings Call Transcript
2024-03-06 19:37:26 ET
Emergent BioSolutions Inc. (EBS)
Q4 2023 Earnings Conference Call
March 06, 2024, 05:00 PM ET
Company Participants
Rich Lindahl - Executive Vice President & Chief Financial Officer
Joe Papa - President and Chief Executive Officer
Paul Williams - Senior Vice President & Head, Products Business
Conference Call Participants
Jessica Fye - JPMorgan
Frank DiLorenzo - Singular Research
Presentation
Operator
Good afternoon, everyone. I'm the operator for today's call. Thank you for joining today as Emergent discusses their Operation and Financial Results for the Fourth Quarter and Full Year. As is customary, today's call is open to all participants, and the call is being recorded and is copyrighted by Emergent BioSolutions.
In addition to today's press release, there is a series of slides accompanying this webcast available to all webcast participants.
Turning to Slide 3. During today's call, Emergent may make projections and other forward-looking statements related to their business, future events, their prospects or future performance. These forward-looking statements are based on their current intentions, beliefs and expectations regarding future events. Any forward-looking statements speaks only as today of this conference call. And as expected by required by law, Emergent does not undertake to update any forward-looking statement to reflect new information, events or circumstances. Investors should consider this cautionary statement as well as risk factors identified in Emergent's periodic reports filed with the SEC when evaluating their forward-looking statements.
During today's call, Emergent may also discuss certain non-GAAP financial measures that involve adjustments to GAAP figures in order to provide greater transparency regarding Emergent's operating performance. Please refer to the table found in today's press release....
Emergent BioSolutions Inc. (EBS) Q4 2023 Earnings Call Transcript